2018
DOI: 10.2146/ajhp170351
|View full text |Cite
|
Sign up to set email alerts
|

Contemporary challenges and novel strategies for health-system formulary management

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 5 publications
0
4
0
Order By: Relevance
“…The TDF domain environmental context and resources , which was linked to formulary and formulary processes being inadequately responsive has been discussed in the literature. Challenges associated with maintaining up-to-date formularies and their cost-effectiveness continues to be debated [ 16 , 51 55 ]. What is clear, however, is the strong consensus that continuous monitoring of NFD prescribing and periodic review of trends are essential parts of formulary management [ 56 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The TDF domain environmental context and resources , which was linked to formulary and formulary processes being inadequately responsive has been discussed in the literature. Challenges associated with maintaining up-to-date formularies and their cost-effectiveness continues to be debated [ 16 , 51 55 ]. What is clear, however, is the strong consensus that continuous monitoring of NFD prescribing and periodic review of trends are essential parts of formulary management [ 56 ].…”
Section: Discussionmentioning
confidence: 99%
“…What is clear, however, is the strong consensus that continuous monitoring of NFD prescribing and periodic review of trends are essential parts of formulary management [ 56 ]. Beyond this, recent studies have advocated for the transition to more relaxed formularies, with expansion of the number of formulary items within selected drug classes in order to avoid the increased workload burden associated with the process of prescribing NFDs [ 55 , 57 59 ]. However, there is likely to be considerable resistance against this approach.…”
Section: Discussionmentioning
confidence: 99%
“…The assessment of medication value is a logical extension of the traditional assessment of cost in the formulary management process. The increasing cost of medications has resulted in a broadening of formulary categories (Table 5) as well as creative solutions to mitigate their financial impact using different pharmacoeconomic models (eg, cost‐minimization, cost utility) as relevant to the drug/disease state 36 . Five value frameworks exist within the oncology landscape, which share a focus on safety and survival but demonstrate variability in methodology and perspective in comparing value as well as framework‐specific advantages and disadvantages 37 .…”
Section: Innovative Methods Of Formulary Managementmentioning
confidence: 99%
“…6 Pharmacoeconomic studies currently explore the economic value of treatment options, but there is a need in the United States for a way to create and distribute improved information on the clinical and economic value of medications. 7 Maintaining a formulary and creating a process for selecting medications for use within a health system is required by the Joint Commission and the National Integrated Accreditation for Healthcare Organizations for accredited hospitals. 8,9 There are minimum criteria for pharmacy & therapeutics (P&T) committees, with the key principles being unbiased review of safety and efficacy.…”
Section: What This Study Addsmentioning
confidence: 99%